Comprehensive investigation and exploration of metoprolol impurities: Novel synthesis, refinement and characterization

Metoprolol, characterized by its chemical nomenclature as 1-[4-(2-Methoxyethyl) phenoxy]-3-[(propan-2-yl) amino]propan-2-ol, possesses a mol. weight of 267.3g/mol., is recognized as a selective blocker of the β1 receptor. It is frequently prescribed for managing hypertension, alleviating chest pain resulting from insufficient Enhancing the circulation of blood to the heart and managing diverse conditions linked to an abnormally elevated heart rate. The objective of the research is to produce essential impurities of metoprolol. In the course of drug development, it is crucial to regulate impurities and ensure they remain within specified limits to achieve high-quality drugs. Numerous studies have been undertaken to synthesize impurities and examine their structures, supporting the purification methods. The integrity of compounds which are synthesized was verified through analyzing the spectral data, including (IR) infrared, (NMR) Nuclear Magnetic Resonance, and (MASS) Mass Spectrometry. Additionally, the purity of these compounds was affirmed through microanalysis.